_id

6910570fccc777a4e85d5665

Ticker

CUE

Name

Cue Biopharma

Exchange

NASDAQ

Address

40 Guest Street, Boston, MA, United States, 02135

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.cuebiopharma.com

Description

Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops a novel class of injectable therapeutics to selectively engage and modulate targeted, disease relevant T cells in the United States. Its lead drug product candidate is the CUE-401, a novel approach to induce and expand antigen specific Tregs for regulating disease causing autoreactive Teff cells which is in preclinical trial; and CUE-501, a treatment of autoimmune disease via anti-viral T cell-mediated depletion of B cells. The company also develops CUE-101, which is in phase 1b clinical trial to treat HPV+ recurrent metastatic, or head and neck squamous cell carcinoma in second line, and beyond patients as a monotherapy, as well as in phase 1b clinical trial for the treatment of head and neck squamous cell carcinoma as a first line, therapy in combination with standard of care KEYTRUDA; and CUE-102, which is in phase 1b clinical trial as a monotherapy in late line recurrent metastatic WT1+ colorectal, gastric, ovarian, and pancreatic cancer. It has collaboration agreements with LG Chem, Ltd. for the development of CUE-101 and CUE-102 Immuno-STATs; collaboration and option agreement with Ono Pharmaceutical Co., Ltd to development and commercialization rights for CUE-401; and license agreement with Albert Einstein College of Medicine. The company was formerly known as Imagen Biopharma, Inc. and changed its name to Cue Biopharma, Inc. in October 2016. Cue Biopharma, Inc. was incorporated in 2014 and is headquartered in Boston, Massachusetts.

Last Close

0.4932

Volume

31978

Current Price

0.4871

Change

-1.2368207623682177

Last Updated

2025-11-29T11:59:34.839Z

Image

data:image/webp;base64,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

Ipo Date

2018-01-02T00:00:00.000Z

Market Cap

49604772

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.9943333333333332

Sentiment Sources

3

Rating

4.5

Target Price

4

Strong Buy

2

Buy

2

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

2149000

Cost Of Revenue

79000

Gross Profit

2069999

Operating Expenses

9614000

Operating Income

-7544000

Interest Expense

75000

Pretax Income

-7448000

Net Income

-7448000

Eps

-0.07383808930897333

Dividends Per Share

-

Shares Outstanding

78737736

Income Tax Expense

-

EBITDA

-7294000

Operating Margin

-351.0469986040019

Total Other Income Expense Net

96000

Cash

11701000

Short Term Investments

6971000

Receivables

2286000

Inventories

-

Total Current Assets

25819000

Property Plant Equipment

4909000

Total Assets

31644000

Payables

2348000

Short Term Debt

3489000

Long Term Debt

-

Total Liabilities

18398000

Equity

13246000

Depreciation

79000

Change In Working Capital

-3617000

Cash From Operations

-9024000

Capital Expenditures

0

Cash From Investing

-6768000

Cash From Financing

1000

Net Change In Cash

-15791000

PE

-

PB

3.7093054429941112

ROE

-56.22829533444058

ROA

-23.53684742763241

FCF

-9024000

Fcf Percent

-4.199162401116799

Piotroski FScore

0

Health Score

19

Deep Value Investing Score

2.5

Defensive Investing Score

6

Dividend Investing Score

1.5

Economic Moat Investing Score

4.3

Garp Investing Score

1.5

Growth Investing Score

1

Momentum Investing Score

4

Net Net Investing Score

2.5

Quality Investing Score

2

Value Investing Score

2.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

2149000

Quarters > 0 > income Statement > cost Of Revenue

79000

Quarters > 0 > income Statement > gross Profit

2069999

Quarters > 0 > income Statement > operating Expenses

9614000

Quarters > 0 > income Statement > operating Income

-7544000

Quarters > 0 > income Statement > interest Expense

75000

Quarters > 0 > income Statement > pretax Income

-7448000

Quarters > 0 > income Statement > net Income

-7448000

Quarters > 0 > income Statement > eps

-0.07383808930897333

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

100869349

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-7294000

Quarters > 0 > income Statement > operating Margin

-351.0469986040019

Quarters > 0 > income Statement > total Other Income Expense Net

96000

Quarters > 0 > balance Sheet > cash

11701000

Quarters > 0 > balance Sheet > short Term Investments

6971000

Quarters > 0 > balance Sheet > receivables

2286000

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

25819000

Quarters > 0 > balance Sheet > property Plant Equipment

4909000

Quarters > 0 > balance Sheet > total Assets

31644000

Quarters > 0 > balance Sheet > payables

2348000

Quarters > 0 > balance Sheet > short Term Debt

3489000

Quarters > 0 > balance Sheet > long Term Debt

-

Quarters > 0 > balance Sheet > total Liabilities

18398000

Quarters > 0 > balance Sheet > equity

13246000

Quarters > 0 > cash Flow > net Income

-7448000

Quarters > 0 > cash Flow > depreciation

79000

Quarters > 0 > cash Flow > change In Working Capital

-3617000

Quarters > 0 > cash Flow > cash From Operations

-9024000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-6768000

Quarters > 0 > cash Flow > cash From Financing

1000

Quarters > 0 > cash Flow > net Change In Cash

-15791000

Quarters > 0 > ratios > PE

-0.07383808930897333

Quarters > 0 > ratios > PB

3.7093054429941112

Quarters > 0 > ratios > ROE

-56.22829533444058

Quarters > 0 > ratios > ROA

-23.53684742763241

Quarters > 0 > ratios > FCF

-9024000

Quarters > 0 > ratios > Piotroski FScore

0

Quarters > 0 > ratios > fcf Percent

-4.199162401116799

Quarters > 0 > health Score

19

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

2954000

Quarters > 1 > income Statement > cost Of Revenue

100000

Quarters > 1 > income Statement > gross Profit

2954000

Quarters > 1 > income Statement > operating Expenses

11589000

Quarters > 1 > income Statement > operating Income

-8635000

Quarters > 1 > income Statement > interest Expense

45000

Quarters > 1 > income Statement > pretax Income

-8482000

Quarters > 1 > income Statement > net Income

-8482000

Quarters > 1 > income Statement > eps

-0.0888545278007768

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

95459401

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-7641000

Quarters > 1 > income Statement > operating Margin

-292.3155044008125

Quarters > 1 > income Statement > total Other Income Expense Net

153000

Quarters > 1 > balance Sheet > cash

27492000

Quarters > 1 > balance Sheet > short Term Investments

470000

Quarters > 1 > balance Sheet > receivables

532000

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

30844000

Quarters > 1 > balance Sheet > property Plant Equipment

5572000

Quarters > 1 > balance Sheet > total Assets

40707000

Quarters > 1 > balance Sheet > payables

3627000

Quarters > 1 > balance Sheet > short Term Debt

4530000

Quarters > 1 > balance Sheet > long Term Debt

-

Quarters > 1 > balance Sheet > total Liabilities

22548000

Quarters > 1 > balance Sheet > equity

18159000

Quarters > 1 > cash Flow > net Income

-8482000

Quarters > 1 > cash Flow > depreciation

796000

Quarters > 1 > cash Flow > change In Working Capital

2966000

Quarters > 1 > cash Flow > cash From Operations

-3415000

Quarters > 1 > cash Flow > capital Expenditures

27000

Quarters > 1 > cash Flow > cash From Investing

-27000

Quarters > 1 > cash Flow > cash From Financing

17798000

Quarters > 1 > cash Flow > net Change In Cash

14356000

Quarters > 1 > ratios > PE

-0.0888545278007768

Quarters > 1 > ratios > PB

2.5606186589074285

Quarters > 1 > ratios > ROE

-46.709620573820146

Quarters > 1 > ratios > ROA

-20.836711130763753

Quarters > 1 > ratios > FCF

-3442000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-1.1651997291807719

Quarters > 1 > health Score

25

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

421000

Quarters > 2 > income Statement > cost Of Revenue

-

Quarters > 2 > income Statement > gross Profit

421000

Quarters > 2 > income Statement > operating Expenses

12720000

Quarters > 2 > income Statement > operating Income

-12299000

Quarters > 2 > income Statement > interest Expense

128000

Quarters > 2 > income Statement > pretax Income

-12257000

Quarters > 2 > income Statement > net Income

-12257000

Quarters > 2 > income Statement > eps

-0.16506699239240075

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

74254700

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-11247000

Quarters > 2 > income Statement > operating Margin

-2921.377672209026

Quarters > 2 > income Statement > total Other Income Expense Net

42000

Quarters > 2 > balance Sheet > cash

13136000

Quarters > 2 > balance Sheet > short Term Investments

-

Quarters > 2 > balance Sheet > receivables

0

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

15931000

Quarters > 2 > balance Sheet > property Plant Equipment

4112000

Quarters > 2 > balance Sheet > total Assets

22254000

Quarters > 2 > balance Sheet > payables

3784000

Quarters > 2 > balance Sheet > short Term Debt

6949000

Quarters > 2 > balance Sheet > long Term Debt

-

Quarters > 2 > balance Sheet > total Liabilities

15674000

Quarters > 2 > balance Sheet > equity

6580000

Quarters > 2 > cash Flow > net Income

-12257000

Quarters > 2 > cash Flow > depreciation

882000

Quarters > 2 > cash Flow > change In Working Capital

1824000

Quarters > 2 > cash Flow > cash From Operations

-8172000

Quarters > 2 > cash Flow > capital Expenditures

150000

Quarters > 2 > cash Flow > cash From Investing

-150000

Quarters > 2 > cash Flow > cash From Financing

-1000000

Quarters > 2 > cash Flow > net Change In Cash

-9322000

Quarters > 2 > ratios > PE

-0.16506699239240075

Quarters > 2 > ratios > PB

5.4968790835866255

Quarters > 2 > ratios > ROE

-186.27659574468086

Quarters > 2 > ratios > ROA

-55.07773883346814

Quarters > 2 > ratios > FCF

-8322000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-19.767220902612827

Quarters > 2 > health Score

16

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

1576000

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

1576000

Quarters > 3 > income Statement > operating Expenses

11209000

Quarters > 3 > income Statement > operating Income

-9633000

Quarters > 3 > income Statement > interest Expense

153000

Quarters > 3 > income Statement > pretax Income

-9496000

Quarters > 3 > income Statement > net Income

-9496000

Quarters > 3 > income Statement > eps

-0.12791236182053614

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

74238329

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-9245000

Quarters > 3 > income Statement > operating Margin

-611.230964467005

Quarters > 3 > income Statement > total Other Income Expense Net

137000

Quarters > 3 > balance Sheet > cash

22459000

Quarters > 3 > balance Sheet > short Term Investments

929000

Quarters > 3 > balance Sheet > receivables

945000

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

25138000

Quarters > 3 > balance Sheet > property Plant Equipment

4841000

Quarters > 3 > balance Sheet > total Assets

32191000

Quarters > 3 > balance Sheet > payables

2823000

Quarters > 3 > balance Sheet > short Term Debt

7873000

Quarters > 3 > balance Sheet > long Term Debt

-

Quarters > 3 > balance Sheet > total Liabilities

14692000

Quarters > 3 > balance Sheet > equity

17499000

Quarters > 3 > cash Flow > net Income

-9496000

Quarters > 3 > cash Flow > depreciation

-238000

Quarters > 3 > cash Flow > change In Working Capital

-901000

Quarters > 3 > cash Flow > cash From Operations

-9028000

Quarters > 3 > cash Flow > capital Expenditures

2000

Quarters > 3 > cash Flow > cash From Investing

-1000

Quarters > 3 > cash Flow > cash From Financing

-932000

Quarters > 3 > cash Flow > net Change In Cash

-9961000

Quarters > 3 > ratios > PE

-0.12791236182053614

Quarters > 3 > ratios > PB

2.066488945419738

Quarters > 3 > ratios > ROE

-54.26595805474599

Quarters > 3 > ratios > ROA

-29.498928271877233

Quarters > 3 > ratios > FCF

-9030000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-5.729695431472082

Quarters > 3 > health Score

31

Valuation > metrics > PE

-0.07383808930897333

Valuation > metrics > PB

3.7093054429941112

Valuation > final Score

42.90694557005889

Valuation > verdict

23.6% Overvalued

Profitability > metrics > ROE

-56.22829533444058

Profitability > metrics > ROA

-28.846973159301292

Profitability > metrics > Net Margin

-3.465798045602606

Profitability > final Score

0

Profitability > verdict

Weak

Risk > metrics > Debt Equity

1.3889476068247018

Risk > metrics > Interest Coverage

-100.58666666666667

Risk > final Score

-372

Risk > verdict

High

Liquidity > metrics > Current Ratio

4.423333904402947

Liquidity > metrics > Quick Ratio

4.423333904402947

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

80

Prev Valuations > 1

25.031209164133745

Prev Valuations > 2

80

Prev Profitabilities > 0

0

Prev Profitabilities > 1

0

Prev Profitabilities > 2

0

Prev Risks > 0

-738

Prev Risks > 1

-366

Prev Risks > 2

-204

Prev Liquidities > 0

100

Prev Liquidities > 1

87

Prev Liquidities > 2

100

Updated At

2025-12-14T00:22:32.261Z